OTC Drug Market 2024
Language:
Japanese
Product Code No:
C66104400
Issued In:
2024/06
#of Pages:
245
Publication Cycle:
Biannual
Format:
PDF
Geographic Coverage:
,
Japan
,
Industry:
Jump to the Japanese Page:
Coverage: (Product/service)
OTC Drugs
Research Target:
Pharmaceutical companies
Research Content:
I OTC Drug Market Perspectives and Strategies
- OTC Market Trends
- OTC Drug Market for 2023 is estimated to have risen by
0.1% on YoY to 840 billion yen - OTC Drug Manufacturer Trends and Strategies
- OTC Drug Market Perspectives
II Status of Major OTC Drugs and Mid-Term Perspectives
- Cold remedies
- Health drinks, bottled medicines
- Vitamin preparations
- Digestive remedies
- Intestinal remedies and antidiarrheal agents
- Antipyretic analgesic
- Eye drops
- Cataplasms and plasters
- Athlete's foot remedies
- Laxatives
- Hemorrhoidal preparations
III OTC Drug Strategies by Major Pharmaceutical Companies
Sales performance, sales of OTC segment, major product trends, sales strategies, R&D trends, Items/efficacies in focus, attempts of new business, overseas development, long-term perspectives
- Alinamin Pharmaceutical Co.,Ltd.
- Eisai Co., Ltd.
- SSP CO., LTD.
- GlaxoSmithKline Consumer Healthcare Japan
- Kobayashi Pharmaceutical Co., Ltd.
- Sato Pharmaceutical Co.,Ltd
- Santen Pharmaceutical Co., Ltd.
- SHIONOGI HEALTHCARE CO., LTD.
- ZERIA Pharmaceutical Co.,Ltd.
- DAIICHI SANKYO HEALTHCARE CO., LTD.
- Taiko Pharmaceutical Co., Ltd.
- Taisho Pharmaceutical Co., Ltd.
- TAIHO PHARMACEUTICAL CO., LTD.
- HISAMITSU PHARMACEUTICAL CO.,INC.
- Lion Corporation.
- ROHTO Pharmaceutical Co.,Ltd.